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Sir,
We agree with Dr. Heaney that it is unclear whether there is any
association between intakes of dairy products and/or calcium and
prostate cancer risk. We had conducted our study, investigating
the possibility that higher intakes of dairy products and/or calcium
may be associated with increased risk, because calcium suppresses
1,25-dihydroxyvitamin D [1,25(OH)2D], which inhibits the pro-
liferation of prostate cancer cells and promotes their differentia-
tion (Koh et al, 2006).
We respectfully disagree with Dr. Heaney’s statement that serum
1,25(OH)2D is unrelated to prostate cancer risk. The data are
presently not clear: some studies have shown strong (Corder et al,
1993) or weak inverse associations (Gann et al,1 9 9 6 ) ,w h i l eo t h e r s
have observed U-shaped (i.e., increased prostate cancer risk with
both low and high levels of 1,25(OH)2D) (Tuohimaa et al, 2004) or
null associations (Nomura et al, 1998). Additionally, two other studies
have reported inverse associations between serum 25-hydroxyvitamin
D[ 2 5 ( O H ) D ]( A h o n e net al, 2000) or predicted serum 25(OH)D
levels and prostate cancer risk (Giovannucci et al, 2006).
Thus, it is biologically plausible – although not proven – for high
intakes of dairy products and/or calcium to be related to increased
prostate cancer risk. While our study and others (Severi et al,
2006) did not observe any association, other large, well-conducted
studies have reported that high intakes are indeed predictive of
increased prostate cancer risk (Giovannucci et al, 1998; Chan et al,
2001). Further studies are needed to clarify the association.
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